A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...

The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...

In a first-in-human phase 1/2a clinical trial, researchers used adult stem cells to help restore vision in people with age-related macular degeneration. In the United States, age-related macular degen ...

The clinical trial enrolled 38 adults aged 60 and older who had advanced geographic atrophy, the late stage of macular ...

Clinicians at the University of Pittsburgh Medical Center are the first in the nation to implant a patient with a wireless retinal device as part of a new clinical trial. The device, called Prima, ...

Age-related macular degeneration is the leading cause of vision loss in those who are age 50 or older. In fact, almost 20 million people in the U.S. have some type of age-related macular degeneration, ...

"When patients get to the advanced stages of AMD, they must have injections in the eye monthly for their entire lives and despite that treatment with an intense regimen, the majority do slowly lose ...

ANNX advances tanruprubart for Guillain-Barré syndrome, with an EMA filing planned for January 2026 and ongoing FDA ...

"These results clearly point to 2 main underlying etiologic mechanisms in central serous chorioretinopathy: choroidal vascular permeability/dysfunction and the ...

The trial is a phase 1/2 open-label, ascending-dose study of the safety and efficacy of OPGx-LCA5. Recently, the company ...

The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...

Judi Dench says macular degeneration has affected her vision. (Karwai Tang/WireImage via Getty Images) Dench has shared in previous interviews that the condition has affected her ability to read ...